These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Further evidence in support of anticoagulant therapy before elective cardioversion of atrial fibrillation. DiMarco JP J Am Coll Cardiol; 1992 Mar; 19(4):856-7. PubMed ID: 1545082 [No Abstract] [Full Text] [Related]
4. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study. Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200 [TBL] [Abstract][Full Text] [Related]
5. Fondaparinux in atrial fibrillation – old dog, new tricks? Lau YC; Brown RA; Lip GY Arch Cardiovasc Dis; 2015 Feb; 108(2):85-7. PubMed ID: 25599831 [No Abstract] [Full Text] [Related]
6. Anticoagulation in nonvalvular atrial fibrillation. Borresen T J La State Med Soc; 1996 Nov; 148(11):479-84. PubMed ID: 8990787 [TBL] [Abstract][Full Text] [Related]
7. [Anticoagulation after successful cardioversion in atrial fibrillation?]. Frantz E; b1tter C; Fleck E Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S12. PubMed ID: 10818998 [No Abstract] [Full Text] [Related]
8. Experience in daily clinical practice of ambulatory cardioversion of atrial fibrillation treated with new oral anticoagulants. Santas E; Méndez J; Martínez-Brotons A; Núñez J; Chorro FJ; Ruiz-Granell R Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):960-1. PubMed ID: 25242661 [No Abstract] [Full Text] [Related]
9. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation. Marchant BG; Timmis AD Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and anticoagulation. Marcus RR; Atwood JE Adv Intern Med; 1999; 44():239-65. PubMed ID: 9929711 [No Abstract] [Full Text] [Related]
11. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated. Densèm CG Am J Cardiol; 1999 Jan; 83(1):140-1. PubMed ID: 10073808 [No Abstract] [Full Text] [Related]
12. Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Cairns JA; Connolly SJ Circulation; 1991 Aug; 84(2):469-81. PubMed ID: 1860192 [No Abstract] [Full Text] [Related]
13. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. Lip GY; Rumley A; Dunn FG; Lowe GD Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473 [TBL] [Abstract][Full Text] [Related]
14. Thromboembolism after negative TEE. Manning WJ; Silverman DI; Douglas PS Circulation; 1994 Dec; 90(6):3121-2. PubMed ID: 7994865 [No Abstract] [Full Text] [Related]
15. Direct current cardioversion of atrial fibrillation--the next 40 years. Manning WJ; Zimetbaum PJ Mayo Clin Proc; 2002 Sep; 77(9):895-6. PubMed ID: 12233920 [No Abstract] [Full Text] [Related]
16. Management of Atrial Fibrillation in Elderly Adults. Desai Y; El-Chami MF; Leon AR; Merchant FM J Am Geriatr Soc; 2017 Jan; 65(1):185-193. PubMed ID: 27910092 [TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation]. Tebbe U Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745 [No Abstract] [Full Text] [Related]
18. Atrial fibrillation in elderly: particularities of management. Alexa ID; Bucur IM; Rusu RI; Ungureanu G Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):376-81. PubMed ID: 21491820 [TBL] [Abstract][Full Text] [Related]
19. Strategies for cardioversion of atrial fibrillation--time for a change? Silverman DI; Manning WJ N Engl J Med; 2001 May; 344(19):1468-70. PubMed ID: 11346813 [No Abstract] [Full Text] [Related]